Was bringt die Anti-VEGF-Therapie im Klinikalltag?
Crossref DOI link: https://doi.org/10.1007/s00347-016-0389-3
Published Online: 2016-11-04
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wiesinger, K.
Reinelt, P.
Ennemoser, A.
Edelmayr, M.
Schönherr, U.
License valid from 2016-11-04